1. Home
  2. GRC vs OCUL Comparison

GRC vs OCUL Comparison

Compare GRC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gorman-Rupp Company (The)

GRC

Gorman-Rupp Company (The)

HOLD

Current Price

$78.44

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$9.86

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRC
OCUL
Founded
1933
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Fluid Controls
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
GRC
OCUL
Price
$78.44
$9.86
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$23.56
AVG Volume (30 Days)
212.3K
3.3M
Earning Date
04-23-2026
05-05-2026
Dividend Yield
1.04%
N/A
EPS Growth
32.03
N/A
EPS
0.68
N/A
Revenue
$682,389,000.00
$1,990,000.00
Revenue This Year
$6.62
$7.93
Revenue Next Year
$4.66
$96.07
P/E Ratio
$116.91
N/A
Revenue Growth
3.44
3.48
52 Week Low
$36.41
$6.23
52 Week High
$92.78
$16.44

Technical Indicators

Market Signals
Indicator
GRC
OCUL
Relative Strength Index (RSI) 42.34 53.27
Support Level $45.19 $9.24
Resistance Level $79.02 $9.93
Average True Range (ATR) 3.24 0.54
MACD -1.55 0.02
Stochastic Oscillator 11.05 27.79

Price Performance

Historical Comparison
GRC
OCUL

About GRC Gorman-Rupp Company (The)

Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of its revenue from the United States.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: